Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Vaccines

• Publication date

  2014-04-10

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1586/14760584.2014.901893PMID 24655026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman–Moore strain) manufactured in India

  2014cited by this paper
• Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study.

  2013cited by this paper
• The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers.

  2013cited by this paper
• Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine

  2013cited by this paper
• Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

  2013cited by this paper
• The global availability of rabies immune globulin and rabies vaccine in clinics providing indirect care to travelers.

  2013cited by this paper
• Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.

  2013cited by this paper
• Rabid Fox Bites and Human Rabies in a Village Community in Southern India: Epidemiological and Laboratory Investigations, Management and Follow-Up

  2013cited by this paper
• Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial

  2013cited by this paper
• Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

  2012cited by this paper
• One clinic visit for pre-exposure rabies vaccination (a preliminary one year study).

  2012cited by this paper
• Fluzone® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults

  2012cited by this paper
• From guidelines to ground reality: maximizing the benefits of IDRV in the fourth year of its implementation.

  2012cited by this paper
• Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

  2012cited by this paper
• Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient

  2012cited by this paper
• Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.

  2012cited by this paper
• Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren

  2011cited by this paper
• The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule--a case series of 420 travelers.

  2011cited by this paper
• Intradermal delivery of vaccines: potential benefits and current challenges.

  2011cited by this paper
• Enabling skin vaccination using new delivery technologies

  2011cited by this paper
• Postexposure rabies prophylaxis completed in 1 week: preliminary study.

  2010cited by this paper
• Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations.

  2010cited by this paper
• Human and dog rabies prevention and control

  2010cited by this paper
• Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.

  2010cited by this paper
• Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route

  2010cited by this paper
• Fractional doses of inactivated poliovirus vaccine in Oman.

  2010cited by this paper
• Microneedle-based vaccines.

  2009cited by this paper
• A Three-Year Clinical Study On Immunogenicity, Safety, and Booster Response of Purified Chick Embryo Cell Rabies Vaccine Administered Intramuscularly or Intradermally to 12- to 18-Month-Old Thai Children, Concomitantly With Japanese Encephalitis Vaccine

  2009cited by this paper
• Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.

  2009cited by this paper
• A Simplified 4-Site Economical Intradermal Post-Exposure Rabies Vaccine Regimen: A Randomised Controlled Comparison with Standard Methods

  2008cited by this paper
• Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

  2008cited by this paper
• Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.

  2008cited by this paper
• Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

  2008cited by this paper
• Taking dendritic cells into medicine

  2007cited by this paper
• Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.

  2007cited by this paper
• Rabies vaccines. WHO position paper.

  2007cited by this paper
• Failures of post-exposure rabies prophylaxis.

  2007cited by this paper
• Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria1

  2006cited by this paper
• Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.

  2006cited by this paper
• Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.

  2006cited by this paper
• Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.

  2006cited by this paper
• Comparison of Safety and Immunogenicity of Purified Chick Embryo Cell Rabies Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV) Using the Thai Red Cross Intradermal Regimen at a Dose of 0.1 ML

  2006cited by this paper
• Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

  2006cited by this paper
• Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.

  2006cited by this paper
• Re-evaluating the burden of rabies in Africa and Asia.

  2005cited by this paper
• Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.

  2005cited by this paper
• The real cost of rabies post-exposure treatments.

  2005cited by this paper
• Langerhans cells and other skin dendritic cells

  2005cited by this paper
• Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals.

  2005cited by this paper
• Assessing the Relationship between Antigenecity and Immunogenecity of Human Rabies Vaccines: Results of a Meta-Analysis

  2005cited by this paper
• Fatal rabies despite appropriate post-exposure prophylaxis.

  2005cited by this paper
• A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

  2005cited by this paper
• Fatal rabies despite appropriate post-exposure prophylaxis.

  2005cited by this paper
• Delivering vaccines into the skin without needles and syringes

  2003cited by this paper
• Potency, sterility and immunogenicity of rabies tissue culture vaccine after reconstitution and refrigerated storage for 1 week.

  2002cited by this paper
• Failure of Pre- and Postexposure Rabies Vaccinations in a Child Infected with HIV

  2001cited by this paper
• Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts.

  2001cited by this paper
• Failure of pre- and postexposure rabies vaccinations in a child infected with HIV.

  2001cited by this paper
• Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies.

  2001cited by this paper
• Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.

  2000cited by this paper
• Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

  2000cited by this paper
• Postexposure rabies vaccination in patients infected with human immunodeficiency virus.

  1999cited by this paper
• Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination.

  1999cited by this paper
• Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial.

  1999cited by this paper
• Additional reports of failure to respond to treatment after rabies exposure in Thailand.

  1999cited by this paper
• Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine.

  1998cited by this paper
• Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients.

  1997cited by this paper
• Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine.

  1995cited by this paper
• What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?

  1990cited by this paper
• Postexposure prophylaxis for rabies with antiserum and intradermal vaccination.

  1990cited by this paper
• Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization.

  1989cited by this paper
• Experience with preexposure rabies vaccination.

  1988cited by this paper
• Acceptability and Efficacy of Purified Vero-Cell Rabies Vaccine in Thai Children Exposed to Rabies

  1988cited by this paper
• Multisite intradermal vaccination using tissue culture vaccine as an economical prophylactic regimen against rabies.

  1988cited by this paper
• Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man.

  1987cited by this paper
• Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine.

  1987cited by this paper
• Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination.

  1987cited by this paper
• Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis

  1987cited by this paper
• Purified chick embryo cell rabies vaccine.

  1986cited by this paper
• Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine.

  1986cited by this paper
• Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.

  1985cited by this paper
• Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis.

  1985cited by this paper
• Chloroquine prophylaxis associated with a poor antibody response to human diploid cell rabies vaccine.

  1984cited by this paper
• Use of post-exposure intradermal rabies vaccination in a rural mission hospital.

  1984cited by this paper
• Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of immunized persons to intradermal booster vaccination.

  1984cited by this paper
• Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens.

  1984cited by this paper
• An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis.

  1983cited by this paper
• Pre-exposure prophylaxis in Peace Corps volunteers with intradermal human diploid cell rabies vaccine.

  1983cited by this paper
• Pre-exposure prophylaxis in Peace Corps volunteers with intradermal human diploid cell rabies vaccine.

  1983cited by this paper
• Human Diploid Cell Rabies Vaccine: Effectiveness of Immunization With Small Intradermal or Subcutaneous Doses

  1982cited by this paper
• Intradermal immunization with human diploid cell rabies vaccine. Serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine.

  1982cited by this paper
• MULTISITE INTRADERMAL ANTIRABIES VACCINATION

  1981cited by this paper
• HUMAN DIPLOID CELL STRAIN RABIES VACCINE

  1976influential reference
• Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum.

  1976cited by this paper
• Successful Immunization of Primates with Rabies Vaccine Prepared in Human Diploid Cell Strain WI-38.∗

  1965cited by this paper

• Health and Economic Burden of Rabies in Northwest Ethiopia

  2025cites this paper
• Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally

  2025cites this paper
• Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice

  2023cites this paper
• Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.

  2022cites this paper
• The Diagnosis, Clinical Course, Treatment, and Prevention of the Rabies Virus

  2021cites this paper
• Human and animal vaccines

  2020cites this paper
• Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.

  2019cites this paper
• Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia.

  2019cites this paper
• Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications.

  2019cites this paper
• Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis

  2018cites this paper
• Rabies Prophylactic Approaches

  2018cites this paper
• Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study.

  2018cites this paper
• Investigating strategies to boost cutaneous varicella zoster virus-specific immune responses in ageing humans

  2018cites this paper
• Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan

  2018cites this paper
• Comparison of Immune Responses following Intradermal and Intramuscular Rabies Vaccination Methods

  2018cites this paper
• Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis

  2018cites this paper
• Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant

  2017cites this paper
• A review of current strategy for rabies prevention and control in the developing world

  2017cites this paper
• Heterogeneity of Rabies Vaccination Recommendations across Asia

  2017cites this paper
• Micro-fractional Epidermal Powder Delivery for Skin Vaccination.

  2016cites this paper
• Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice

  2016cites this paper
• Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis

  2016cites this paper
• Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets

  2016cites this paper
• In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers

  2016cites this paper
• Mass vaccination of dogs, control of canine populations and post‐exposure vaccination – necessary but not sufficient for achieving childhood rabies elimination

  2015cites this paper
• The prevention and management of rabies

  2015cites this paper
• Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes

  2015cites this paper